Safety and Efficacy Study of Novel Gene Therapy ZM-02 for Retinitis Pigmentosa Patients (clinicaltrials.gov) - Mar 5, 2024 - P1 | N=12 | Not yet recruiting | Sponsor: Zhongmou Therapeutics
Gene therapy • New P1 trial • Gene Therapies • Genetic Disorders • Inherited Retinal Dystrophy • Ocular Inflammation • Ophthalmology • Retinal Disorders • Retinitis Pigmentosa
|